Overall, this study reinforces the hypothesis that activating TRPM8 could play a protective role in prostate cancer progression, thus supporting its potential application as a powerful therapeutic target antagonizing the metastatic transition of PCa. The gene discussed is TRPM8; the disease is prostate cancer.